viimane versioon :
22/08/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Tirofiban
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Aggrastat
Ameerika ühendriigid, Araabia Ühendemiraadid, Austraalia, Austria, Belgia, Holland, Iirimaa, Iraan, Itaalia, Kanada, Luksemburg, Malaisia, Norra, Poola, Portugal, Rootsi, Saksamaa, Saudi Araabia, Soome, Suurbritannia, Sveits, Taani, Türgi, Ungari, uus-Meremaa
Agrastat
Argentiina, Brasiilia, Ecuador, Egiptus, Hispaania, Kolumbia, Maroko, Maroko, Mehhiko, Prantsusmaa, Tšiili, Venetsueela
Thrombostat
Türgi
Tirofiban
Hispaania, Saksamaa
Tiroprest
Türgi
Welban
Hispaania
Xtraban
India
Viited : Tirofiban
tüüp
avaldamine
1071
ajaleht
Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA.
Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets.
Am J Health-Syst Pharm 1999 ; 56: 1627-1629.
1420
ajaleht
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
J Clin Pharm Ther 1999 ; 24: 125-132.
1508
ajaleht
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
1512
Labor
Tirofiban (Aggrastat®) - Summary of Product Characteristics
Beacon Pharmaceuticals Ltd 2015
1600
ajaleht
Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I.
Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days.
Am J Health-Syst Pharm 2001 ; 58: 1850-1851.
1603
ajaleht
Bergquist PA, Manas D, Hunke WA, Reed RA.
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
1611
ajaleht
Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506.
1713
ajaleht
Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
2004
ajaleht
Patel K, Hursting MJ.
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
3823
ajaleht
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
Mentions Légales